 Merck to study once-daily raltegravir dosing, participants wanted |
Nizoral online is used for treating fungal infections. It may also be used for other conditions as determined by your doctor. Buy nizoral online is an azole antifungal. It kills sensitive fungi by interfering with the formation of the fungal cell membrane. Many prescription and nonprescription medicines (eg, used for infections, HIV, seizures, anxiety, sleep, heartburn, diabetes, high cholesterol pills, heart problems, high blood pressure treatment, allergies tablets, irregular heartbeat, pain, blood thinning, asthma, migraines, mood or mental problems, cancer, prostate problems, immune system suppression, erectile dysfunction, urinary problems, or contraception [birth control]), multivitamin products, and herbal or dietary supplements may interact with Nizoral, increasing the risk of serious side effects.
  |
 Oct 14 2008, 02:53 PM
Post
#1
|
|
 Administrator  Group: Root Admin Posts: 489 Joined: 10-July 08 Member No.: 1  |
A chemical engineer at Cambridge University has devised a simple nipple shield that prevents HIV transmission Pharmaceutical producer Merck and Co., Inc. recently announced that it will begin studying one of its HIV drugs, raltegravir (Isentress), for use in once-daily dosing.
Raltegravir was the first, and currently the only, integrase inhibitor available to the pubic. Integrase inhibitors, a developing class of medications used to target HIV, work in collaboration with other HIV drugs to impact the replication of the virus. Specifically, these drugs intervene where HIV actually integrates itself into human DNA. Currently, raltegravir is prescribed twice-daily as a part of an antiretroviral regimen. This new study, referred to as QDMARK, will compare this dosage with a once-daily dosage, with emtricitabtine and tenofovir (Truvada) prescribed as the additional necessary components of therapy for participants. The study will enroll 750 patients at 94 centers in 21 countries. Patients interested in taking part in the QDMARK clinical trial are encouraged to speak with their physician. For more information, please visit www.benchmrk.com and click on QDMRK. |
 |
 
|
|
1 User(s) are reading this topic (1 Guests and 0 Anonymous Users)
0 Members:
| Lo-Fi Version | Time is now: 24th May 2013 - 12:50 AM |